云南白药(000538) - 2025年12月12日投资者关系活动记录表（二）

Group 1: Investor Meeting Overview - The investor meeting was attended by 32 participants from various institutions, including Hongsike Asset, Guangzhou Shuncong Investment, and Shenzhen Qichuang Group [1] - The meeting took place on December 12, 2025, at the company's headquarters [1] - The reception was managed by the investor relations team, specifically Zhang Yu and Yang Kexin [1] Group 2: Meeting Purpose - The primary focus of the meeting was to understand the company's production and operational status [1]